Lodenafil carbonate

DB11927InvestigationalSmall molecule

Lodenafil carbonate has been used in trials studying the treatment of Coronaropathy and Erectile Dysfunction.

Mechanism: Pharmacologically active on cGMP-specific 3',5'-cyclic phosphodiesterase
Curator reviewed
Formula / weight: C₄₇H₆₂N₁₂O₁₁S₂ · 1035.21 g/mol (avg)

Resolves to

Compound

Structure

CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CCOC(=O)OCCN2CCN(CC2)S(=O)(=O)C2=CC=C(OCC)C(=C2)C2=NC3=C(N(C)N=C3CCC)C(=O)N2)CC1

Targets

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Lodenafil carbonate, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.